Close

International: National Export Initiative

Jul 26 2010

Biotechnology companies would be less likely to export their products into countries that do not provide meaningful IP and data protections

Biodefense: Pandemic Influenza and the BioShield Special Reserve Fund (SRF) in HR 4899

Jul 26 2010

...

NIH: Conflict of Interest Rules

Jul 20 2010

...

FDA: Transparency Initiative

Jul 20 2010

...

NIH: Objectivity in Research for Which Public Health Funding Is Sought

Jul 20 2010

...

Medicare: Medicare Coverage Gap Discount Program

Jul 16 2010

...

Manufacturing Practices: Revisions to Europe’s cGMP Guide

Jul 15 2010

...

Comparative Effectiveness: Patient Protection and Affordable Care Act (PPACA)

Jul 12 2010

Biodefense: Executive Order from President Obama Related to the Select Agents Program

Jul 2 2010
Optimizing the Security of Biological Select Agents and Toxins in The United States

Genetically Engineered Plants: USDA’s APHIS Plans to Prepare an Environmental Impact Statement (EIS) in Connection with a Court-Mandated Evaluation of the potential Impacts on the Human Environment Associated with the Glyphosate-tolerant Sugarbeet Line

Jun 28 2010

BIO applauds APHIS’ decision to request that EPA serve as a cooperating agency in preparing this EIS, and encourages APHIS to also use EPA’s human health risk assessment.